These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 34536757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.
    Aldrich JV, Patkar KA, McLaughlin JP.
    Proc Natl Acad Sci U S A; 2009 Oct 27; 106(43):18396-401. PubMed ID: 19841255
    [Abstract] [Full Text] [Related]

  • 3. Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gαz as Shown with Bioluminescence Resonance Energy Tranfer.
    Barnett ME, Knapp BI, Bidlack JM.
    Mol Pharmacol; 2020 Oct 27; 98(4):462-474. PubMed ID: 32958572
    [Abstract] [Full Text] [Related]

  • 4. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY.
    J Pharmacol Exp Ther; 1997 Aug 27; 282(2):676-84. PubMed ID: 9262330
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
    Li JG, Zhang F, Jin XL, Liu-Chen LY.
    J Pharmacol Exp Ther; 2003 May 27; 305(2):531-40. PubMed ID: 12606694
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L, Stahl EL, Lovell KM, Frankowski KJ, Prisinzano TE, Aubé J, Bohn LM.
    Neuropharmacology; 2015 Dec 27; 99():131-41. PubMed ID: 26160155
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S, Aldrich JV, Walker BM.
    Alcohol; 2016 Mar 27; 51():43-9. PubMed ID: 26992699
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J, Frankowski KJ, Prisinzano TE, Aubé J, Bohn LM.
    Neuropharmacology; 2015 Dec 27; 99():600-9. PubMed ID: 26318102
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes.
    Peterson PK, Gekker G, Lokensgard JR, Bidlack JM, Chang AC, Fang X, Portoghese PS.
    Biochem Pharmacol; 2001 May 01; 61(9):1145-51. PubMed ID: 11301048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.